168 related articles for article (PubMed ID: 20668647)
1. Off Label Antiviral Therapeutics for Henipaviruses: New Light Through Old Windows.
Aljofan M; Lo MK; Rota PA; Michalski WP; Mungall BA
J Antivir Antiretrovir; 2010 Jan; 2(1):1-10. PubMed ID: 20668647
[TBL] [Abstract][Full Text] [Related]
2. 4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.
Hotard AL; He B; Nichol ST; Spiropoulou CF; Lo MK
Antiviral Res; 2017 Aug; 144():147-152. PubMed ID: 28629988
[TBL] [Abstract][Full Text] [Related]
3. Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
Dawes BE; Kalveram B; Ikegami T; Juelich T; Smith JK; Zhang L; Park A; Lee B; Komeno T; Furuta Y; Freiberg AN
Sci Rep; 2018 May; 8(1):7604. PubMed ID: 29765101
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Henipavirus infection by RNA interference.
Mungall BA; Schopman NC; Lambeth LS; Doran TJ
Antiviral Res; 2008 Dec; 80(3):324-31. PubMed ID: 18687361
[TBL] [Abstract][Full Text] [Related]
6. Hendra and Nipah viruses: pathogenesis and therapeutics.
Eaton BT; Broder CC; Wang LF
Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of paramyxoviruses and filoviruses to inhibition by 2'-monofluoro- and 2'-difluoro-4'-azidocytidine analogs.
Lo MK; Jordan PC; Stevens S; Tam Y; Deval J; Nichol ST; Spiropoulou CF
Antiviral Res; 2018 May; 153():101-113. PubMed ID: 29601894
[TBL] [Abstract][Full Text] [Related]
8. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
Rockx B; Bossart KN; Feldmann F; Geisbert JB; Hickey AC; Brining D; Callison J; Safronetz D; Marzi A; Kercher L; Long D; Broder CC; Feldmann H; Geisbert TW
J Virol; 2010 Oct; 84(19):9831-9. PubMed ID: 20660198
[TBL] [Abstract][Full Text] [Related]
9. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling.
Rodriguez JJ; Horvath CM
Viral Immunol; 2004; 17(2):210-9. PubMed ID: 15279700
[TBL] [Abstract][Full Text] [Related]
10. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.
Porotto M; Orefice G; Yokoyama CC; Mungall BA; Realubit R; Sganga ML; Aljofan M; Whitt M; Glickman F; Moscona A
J Virol; 2009 May; 83(10):5148-55. PubMed ID: 19264786
[TBL] [Abstract][Full Text] [Related]
11. Hendra and Nipah infection: emerging paramyxoviruses.
Aljofan M
Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in henipavirus research: molecular biology, genetic diversity, animal models.
Rockx B; Winegar R; Freiberg AN
Antiviral Res; 2012 Aug; 95(2):135-49. PubMed ID: 22643730
[TBL] [Abstract][Full Text] [Related]
13. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
14. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
15. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.
Sugai A; Sato H; Takayama I; Yoneda M; Kai C
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835499
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
[TBL] [Abstract][Full Text] [Related]
17. [Nipah and Hendra virus infectious diseases].
Yoneda M
Nihon Rinsho; 2016 Dec; 74(12):1973-1978. PubMed ID: 30550652
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.
Bossart KN; Mungall BA; Crameri G; Wang LF; Eaton BT; Broder CC
Virol J; 2005 Jul; 2():57. PubMed ID: 16026621
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.
Pallister J; Middleton D; Crameri G; Yamada M; Klein R; Hancock TJ; Foord A; Shiell B; Michalski W; Broder CC; Wang LF
J Virol; 2009 Nov; 83(22):11979-82. PubMed ID: 19759137
[TBL] [Abstract][Full Text] [Related]
20. The changing face of the henipaviruses.
Croser EL; Marsh GA
Vet Microbiol; 2013 Nov; 167(1-2):151-8. PubMed ID: 23993256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
